REDHILL BIOPHARMA LTD. (RDHL) Operating cash flow 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.4MFY2024 · since FY2015: -$17.8M → -$9.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$9.4M | +73.8% |
| FY2023 | -$35.8M | -22.7% |
| FY2022 | -$29.2M | +55.1% |
| FY2021 | -$65.0M | -33.9% |
| FY2020 | -$48.6M | -19.2% |
| FY2019 | -$40.7M | -18.2% |
| FY2018 | -$34.5M | +23.0% |
| FY2017 | -$44.8M | -58.4% |
| FY2016 | -$28.3M | -58.5% |
| FY2015 | -$17.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice